Geoffrey von Maltzahn works at the frontier of generative biology, using AI to learn the rules of DNA and proteins so that entirely new medicines can be generated rather than discovered through trial-and-error, and he holds the rare dual role of both Flagship general partner and serial founding CEO of multiple companies like Tessera Therapeutics and Lila Sciences. He advocates for scientific superintelligence through AI-driven automated science factories that continuously run experiments, and he treats entrepreneurship as a trainable craft by pairing founding scientists with world-class capabilities so first-time entrepreneurs can operate at the level of mature companies.

• A strong focus on the intersection of artificial intelligence and biology, specifically how generative models can be applied to the "languages of life" rather than just human text. He views this as a shift from probabilistic to deterministic drug development, frequently citing examples of using AI to invent antibodies or design novel proteins that never existed in nature before.
• Deep interest in the next generation of genetic medicines, particularly technologies that allow for precise "gene writing" within the human body. He enthusiastically shares technical milestones, such as using lipid nanoparticles to deliver RNA payloads that can engineer T cells in vivo, effectively creating new categories of therapeutics for difficult diseases.
• Commitment to the microbiome as a powerful frontier for both human health and agriculture. He tracks the journey of microbiome therapeutics from "crazy ideas" to approved medicines for conditions like C. diff infections, while simultaneously highlighting how plant microbiomes can protect seeds from pathogens and improve crop resilience.
• Advocacy for regenerative agriculture as a massive-scale solution for climate change and carbon capture. He uses vivid analogies to visualize the impact of carbon farming, comparing the weight of carbon sequestered by growers to the Washington Monument or thousands of elephants to emphasize the potential of nature-based solutions.
• Appreciation for the convergence of art, science, and entrepreneurship. He draws parallels between historical figures like Leonardo da Vinci and modern founders, suggesting that compartmentalizing these fields is a mistake and that successful innovation requires blending scientific rigor with creativity and grit.